Background: There is a high prevalence of depression in people with spinal injury. It has a major negative influence on health and performance of daily living activities following the injury. Social support plays an important ...

Introduction: Evidence supporting pharmacogenetic (PGX) tests utility in depression is scarce. The main objectives of this study were to summarize, update, and assess the quality of the available evidence regarding PGX ...

Depression is associated with several chronic diseases such as diabetes. Diabetes is a long-term health disorder that have many health complications such as mental health problems, if left untreated. Our study aimed to ...

There is limited data from Arabic-speaking countries on risk factors for depression and anxiety during the COVID-19 pandemic. Country-specific data is necessary given differences in culture, demographics, and COVID-19 ...

Background: There is emerging evidence that supports a role for inflammatory processes and insomnia in the pathophysiology of depression. However, little is known about the role of inflammation in depression and insomnia ...

Background: Negative attitudes and stigma to mental health constitute major barriers to healthcare provision and access to treatment for patients with depression across the globe. Community pharmacists are among the most ...

Aims: To estimate the prevalence of Insomnia Disorder in the household population of Qatar and explore potential associations with depressive and anxiety symptoms in addition to sociodemographic variables. Methods: ...

Aims: QLAMP aims to identify risk factors and resilience factors for symptoms of psychiatric illness during the pandemic. Study strengths include the 1-year longitudinal design and the use of standardised instruments already ...